title: Serum visfatin levels do not increase in post-menopausal women with metabolic syndrome.
abstract: BACKGROUND
  The aim of this study was to determine the serum visfatin levels in post-menopausal (PM) women with and without metabolic syndrome (MS) and to understand the correlation between serum visfatin levels and various other hormonal and metabolic parameters.
  
  
  METHODS
  We conducted a prospective cross-sectional study including 17 PM women with MS and a control group of 51 PM women without MS. MS was defined according to the National Cholesterol Education Program Adult Treatment Panel III.
  
  
  RESULTS
  Women with MS had statistically significantly higher fasting blood glucose, HDL, triglycerides, insulin, homeostasis model assessment of insulin resistance, and SHBG levels when compared to women without MS. Estradiol, high sensitivity C-reactive protein, and free testosterone levels were higher in the MS group, but there was no statistically significant difference between the two groups. Visfatin levels did not differ between the two groups. There was no correlation between serum visfatin levels and other parameters.
  
  
  CONCLUSIONS
  There was no association between serum visfatin levels and MS in PM women.
authors.affiliation: Department of Obstetrics and Gynecology, Istanbul Bilim University, Avrupa Hospital, Istanbul, Turkey. nilgun.kutay@gmail.com
authors.forename: N
authors.initials: N
authors.lastname: Güdücü
authors.forename: H
authors.initials: H
authors.lastname: İsçi
authors.forename: U
authors.initials: U
authors.lastname: Görmüş
authors.forename: A B
authors.initials: AB
authors.lastname: Yiğiter
authors.forename: İ
authors.initials: İ
authors.lastname: Dünder
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000502:physiology; D015992:Body Mass Index; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D016207:Cytokines / Q000097:blood*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000502:physiology; D024821:Metabolic Syndrome / Q000097:blood* / Q000453:epidemiology / Q000503:physiopathology; D008875:Middle Aged; D054409:Nicotinamide Phosphoribosyltransferase / Q000097:blood*; D017698:Postmenopause / Q000097:blood* / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
chemical_list: D016207:Cytokines; D007328:Insulin; D014280:Triglycerides; D054409:Nicotinamide Phosphoribosyltransferase; C085455:nicotinamide phosphoribosyltransferase, human
references.citation: Circulation. 2004 Jul 27;110(4):380-5
references.pmid: 15262834
references.citation: J Clin Endocrinol Metab. 1993 Feb;76(2):275-8
references.pmid: 8432768
references.citation: Gynecol Endocrinol. 2009 Apr;25(4):241-5
references.pmid: 19408173
references.citation: Eur J Clin Invest. 2008 Jan;38(1):71-2
references.pmid: 18173555
references.citation: JAMA. 2006 Mar 15;295(11):1288-99
references.pmid: 16537739
references.citation: Maturitas. 2010 Sep;67(1):67-71
references.pmid: 20537826
references.citation: Diabetes. 2005 Oct;54(10):2911-6
references.pmid: 16186392
references.citation: J Clin Endocrinol Metab. 2007 Mar;92(3):895-901
references.pmid: 17192296
references.citation: Gynecol Endocrinol. 2011 Jul;27(7):475-9
references.pmid: 20586547
references.citation: Diabetes Res Clin Pract. 2008 Jan;79(1):108-11
references.pmid: 17904242
references.citation: Am J Epidemiol. 2002 Mar 1;155(5):437-45
references.pmid: 11867355
references.citation: Clin Endocrinol (Oxf). 2007 Nov;67(5):796-800
references.pmid: 17634078
references.citation: Mol Cell Biol. 1994 Feb;14(2):1431-7
references.pmid: 8289818
references.citation: Fertil Steril. 2006 Dec;86(6):1669-75
references.pmid: 17074346
references.citation: Clin Endocrinol (Oxf). 2008 Dec;69(6):878-84
references.pmid: 18363885
references.citation: Metabolism. 2007 Sep;56(9):1216-20
references.pmid: 17697864
references.citation: Diabetes Res Clin Pract. 2009 Jul;85(1):24-9
references.pmid: 19403191
references.citation: Diabetes Care. 2007 Mar;30(3):701-6
references.pmid: 17327344
references.citation: J Clin Endocrinol Metab. 2010 Sep;95(9):4258-67
references.pmid: 20534759
references.citation: Diabetes Obes Metab. 2007 Jul;9(4):490-7
references.pmid: 17587391
references.citation: JAMA. 2001 May 16;285(19):2486-97
references.pmid: 11368702
references.citation: Science. 2005 Jan 21;307(5708):426-30
references.pmid: 15604363
references.citation: J Clin Endocrinol Metab. 2006 Aug;91(8):3165-70
references.pmid: 16720654
references.citation: JAMA. 1998 Dec 2;280(21):1843-8
references.pmid: 9846779
references.citation: Am J Cardiol. 2002 Aug 15;90(4):364-8
references.pmid: 12161223
references.citation: Eur J Intern Med. 2008 Oct;19(6):406-12
references.pmid: 18848173
references.citation: Cytokine. 2010 Mar;49(3):275-8
references.pmid: 20045351
references.citation: Diabetes Care. 2002 Jan;25(1):55-60
references.pmid: 11772901
references.citation: Arch Intern Med. 2003 Feb 24;163(4):427-36
references.pmid: 12588201
references.citation: Diabetes. 2006 Jun;55(6):1537-45
references.pmid: 16731815